|
|
||||||||
1 Department of Microbiology and Nutrition Research, The Upjohn Company, Kalamazoo, Michigan 49001
2 Department of Microbiology, College of Physicians & Surgeons of Columbia University, New York, New York 10032
3 Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, Shreveport, Louisiana 71130-3932
4 Department Microbiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799
and5 Department of Microbiology, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee 37996-0845, U.S.A.
Vaccinia virus recombinants expressing the herpes simplex virus type 1 (HSV-1) genes encoding ICP0 or ICP4 were used to identify the precise target antigen(s) of murine anti-viral cytotoxic T lymphocytes (CTL) specific for the non-structural immediate early proteins. These studies revealed that HSV-1-specific CTL, restricted to class I major histocompatibility complex genes of the H-2k haplotype but not the H-2d or H-2b haplotypes, would lyse autologous cells expressing ICP4. HSV-1-specific CTL derived from various mice strains failed to lyse target cells expressing ICP0. Calculation of the frequencies of H-2k-restricted virus-specific CTL demonstrated that approximately a third of the total HSV-1-specific response was directed against ICP4. Immunization of mice with either recombinant vaccinia virus or transfected L cells expressing ICP4 induced HSV-1-specific lymphoproliferation and delayed hypersensitivity but CTLs were not induced. More importantly, such immunized animals were unable to resist or control a subsequent challenge with virulent HSV-1.
Received 18 January 1990;
accepted 5 June 1990.
This article has been cited by other articles:
![]() |
J. E. Knickelbein, S. Divito, and R. L. Hendricks Modulation of CD8+ CTL Effector Function by Fibroblasts Derived from the Immunoprivileged Cornea Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2194 - 2202. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Keadle, L. A. Morrison, J. L. Morris, J. S. Pepose, and P. M. Stuart Therapeutic Immunization with a Virion Host Shutoff-Defective, Replication-Incompetent Herpes Simplex Virus Type 1 Strain Limits Recurrent Herpetic Ocular Infection J. Virol., March 19, 2002; 76(8): 3615 - 3625. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mikloska, M. Ruckholdt, I. Ghadiminejad, H. Dunckley, M. Denis, and A. L. Cunningham Monophosphoryl Lipid A and QS21 Increase CD8 T Lymphocyte Cytotoxicity to Herpes Simplex Virus-2 Infected Cell Proteins 4 and 27 Through IFN-{gamma} and IL-12 Production J. Immunol., May 15, 2000; 164(10): 5167 - 5176. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Nash T Cells and the Regulation of Herpes Simplex Virus Latency and Reactivation J. Exp. Med., April 24, 2000; 191(9): 1455 - 1458. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |